ADMA Biologics Stock Target Price and Analyst Consensus
ADMA Stock | USD 6.60 0.14 2.08% |
The current analyst and expert consensus on ADMA Biologics is Strong Buy, with 3 strong buy opinions. The current projected ADMA Biologics target price consensus is 6.0 with 4 analyst opinions. The most common way ADMA Biologics analysts use to provide recommendation to the public is financial statements analysis. Many experts also interview ADMA Biologics executives and customers to further validate their buy or sell advice. Please note, the number of analysts providing the opinion is not sufficient to provide adequate consensus on ADMA Biologics. We encourage you to use your own analysis of ADMA Biologics to validate this buy or sell advice. ADMA Biologics buy-or-sell recommendation module provides average expert sentiment on the projected ADMA Biologics target price to derive its highest and lowest estimates based on its projected price volatility. Check out Macroaxis Advice on ADMA Biologics to cross-verify analyst projections. Unlike analyst recommendations, Macroaxis provides advice only from the perspective of investor risk tolerance and investment horizon. For information on how to trade ADMA Stock refer to our How to Trade ADMA Stock guide.
Lowest Forecast 5.46 | Highest Forecast 6.66 | Target Price 6 |
ADMA |
It's important to approach ADMA Biologics' target price projections with caution. While they can be useful as part of a broader investment strategy, they are inherently speculative and subject to various kinds of risk, including market volatility and unforeseen external factors. Always consider multiple aspects and do your own research when making investment decisions.
ADMA Biologics Target Price Consensus
We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. ADMA target price is determined by taking all analyst projections and averaging them out. There is no one specific way to measure analysts' performance other than comparing it to past results via a very sophisticated attribution analysis. ADMA Biologics' target price projections below should be used in combination with other traditional price prediction techniques such as stock price forecasting, investor sentiment analysis, technical analysis, earnings estimate, and various momentum models.
4 | Strong Buy |
Most ADMA analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to help potential investors understand ADMA stock's fair price compared to its market value. Analysts arrive at stock ratings after researching the public financial statements of ADMA Biologics, talking to its executives and customers, or listening to those companies' conference calls.
Macroaxis Advice Exposure ValuationADMA Biologics Target Price Projection
ADMA Biologics' current and average target prices are 6.60 and 6.00, respectively. The current price of ADMA Biologics is the price at which ADMA Biologics is currently trading. On the other hand, ADMA Biologics' target price is what analysts think the stock is worth or could sell for in the future. The more significant the discrepancy between the two prices, the more it stimulates investors to act.Current Price
ADMA Biologics Market Quote on 29th of March 2024
Target Price
Analyst Consensus On ADMA Biologics Target Price
ADMA Biologics Analyst Ratings
ADMA Biologics' analyst stock recommendations are determined by taking an average estimate of all analysts we track and classifying them as Strong Buy, Buy, Hold, Strong Sell, or Sell. Ratings generally communicate what analysts sense about ADMA Biologics stock, and they use a lot of effort and time to analyze it and arrive at a rating. That suggests that analyst recommendations are the outcome of an objective and thorough examination of ADMA Biologics' financials, market performance, and future outlook by experienced professionals. ADMA Biologics' historical ratings below, therefore, can serve as a valuable tool for investors.Analyst Consensus Breakdown
Average Consensus Estimates
Analysts determine stock price targets through various methods, including financial modeling, peer comparison, and company analysis. The stock price target is the analyst's best estimate of the future price of a stock and is used by investors to make investment decisions. However, it is important to note that stock price targets are not guaranteed, and the actual price of a stock can differ significantly from the target due to various factors such as market conditions, economic events, and company developments.
Steps to utilize ADMA Biologics price targets
ADMA Biologics' stock target price is an estimate of its future price, usually made by analysts. Using ADMA Biologics' target price to determine if it is a suitable investment can be done through the following steps:- Look at ADMA Biologics' target prices provided by various analysts and compare them. This can help you gain a more balanced view of the Stock's potential.
- Look at the analyst's track record to determine if they have a history of accurately predicting stock prices.
- Look at the Company's financials, including revenue, earnings, and debt, to determine if it is in good financial health.
- Consider market conditions. For example, take into account the state of the economy, competition, and regulatory environment, to determine if ADMA Biologics' stock is likely to perform well.
- Diversify your portfolio and do not rely solely on stock target prices to make investment decisions. Invest in a mix of stocks, bonds, and other assets to manage risk.
Additional ADMA Biologics Value Projection Modules
Most investment researchers agree that the mispricing and readjustment of any Stock value happens often and is sometimes even predictable, but there is no strong theory explaining why it happens. The current price of ADMA Biologics is a key component of ADMA Biologics valuation and have some predictive power on the future returns of a ADMA Biologics.Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of ADMA Biologics' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Trending Themes
If you are a self-driven investor, you will appreciate our idea-generating investing themes. Our themes help you align your investments inspirations with your core values and are essential building blocks of your portfolios. A typical investing theme is an unweighted collection of up to 20 funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of equities with common characteristics such as industry and growth potential, volatility, or market segment.Cleaning Invested over 100 shares | ||
Business Services Invested few shares | ||
Macroaxis Index Invested over 200 shares | ||
Baby Boomer Prospects Invested over 40 shares | ||
Warren Buffett Holdings Invested few shares | ||
Check out Macroaxis Advice on ADMA Biologics to cross-verify analyst projections. Unlike analyst recommendations, Macroaxis provides advice only from the perspective of investor risk tolerance and investment horizon. For information on how to trade ADMA Stock refer to our How to Trade ADMA Stock guide.You can also try the Idea Analyzer module to analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas.
Complementary Tools for ADMA Stock analysis
When running ADMA Biologics' price analysis, check to measure ADMA Biologics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy ADMA Biologics is operating at the current time. Most of ADMA Biologics' value examination focuses on studying past and present price action to predict the probability of ADMA Biologics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move ADMA Biologics' price. Additionally, you may evaluate how the addition of ADMA Biologics to your portfolios can decrease your overall portfolio volatility.
Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
AI Investment Finder Use AI to screen and filter profitable investment opportunities | |
Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing |
The data published in ADMA Biologics' official financial statements usually reflect ADMA Biologics' business processes, product offerings, services, and other fundamental events. But there are other numbers, ratios, or fundamental indicators derived from these statements that are easier to understand and visualize within the underlying realities that drive quantitative information of ADMA Biologics. For example, before you start analyzing numbers published by ADMA accountants, it's critical to develop an understanding of what ADMA Biologics' liquidity, profitability, and earnings quality are in the context of the Biotechnology space in which it operates.
Please note, the presentation of ADMA Biologics' financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, ADMA Biologics' management is honest, while the outside auditors are strict and uncompromising. Whatever the case, the imprecision that can be found in ADMA Biologics' accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of ADMA Biologics. Please utilize our Beneish M Score to check the likelihood of ADMA Biologics' management manipulating its earnings.